You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Last Updated: February 22, 2020

DrugPatentWatch Database Preview

Litigation Details for Biogen International GmbH v. Amneal Pharmaceuticals LLC (D. Del. 2017)

Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

Biogen International GmbH v. Amneal Pharmaceuticals LLC (D. Del. 2017)

Docket	Start Trial	Date Filed	2017-06-26
Court	District Court, D. Delaware	Date Terminated
Cause	35:271 Patent Infringement	Assigned To	Leonard Philip Stark
Jury Demand	Defendant	Referred To
Parties	ACCORD HEALTHCARE INC.; ALKEM LABORATORIES LTD.; AMNEAL PHARMACEUTICALS LLC; AUROBINDO PHARMA U.S.A., INC.; AUROBINDO PHARMA USA LLC; BIOGEN INTERNATIONAL GMBH; BIOGEN MA INC.; CARIBE HOLDINGS (CAYMAN) CO. LTD.; CIPLA LIMITED; CIPLA USA INC.; DBA PURACAP CARIBE; GLENMARK PHARMACEUTICALS INC. USA; GLENMARK PHARMACEUTICALS LIMITED; GRAVITI PHARMACEUTICALS INC.; GRAVITI PHARMACEUTICALS PVT. LTD.; HETERO LABS LIMITED; HETERO LABS LIMITED UNIT-III; HETERO USA INC.; IMPAX LABORATORIES INC.; IMPAX LABORATORIES LLC; LUPIN ATLANTIS HOLDINGS SA; MACLEODS PHARMA USA, INC.; MACLEODS PHARMACEUTICALS LTD.; MSN LABORATORIES PRIVATE LTD.; MSN PHARMACEUTICALS INC.; PHARMATHEN S.A.; PRINSTON PHARMACEUTICAL INC.; PURACAP INTERNATIONAL LLC; S&B PHARMA, INC.; SANDOZ INC.; SAWAI PHARMACEUTICAL CO., LTD.; SAWAI USA INC.; SHILPA MEDICARE LIMITED; SLAYBACK PHARMA INDIA LLP; SLAYBACK PHARMA LLC; SUN PHARMA GLOBAL FZE; TEVA PHARMACEUTICALS USA INC.; TORRENT PHARMA INC.; TORRENT PHARMACEUTICALS LTD.; TWI PHARMACEUTICALS INC.; TWI PHARMACEUTICALS USA INC.; WINDLAS HEALTHCARE PVT. LTD.; ZYDUS PHARMACEUTICALS (USA) INC.
Patents	6,509,376; 7,320,999; 7,619,001; 7,803,840; 8,399,514; 8,759,393
Attorneys	Aaron F. Barkoff; Adam Wyatt Poff; Alan Tenenbaum; Alejandro Menchaca; Alison M. Hill; Andrew Colin Mayo; Andrew E. Renison; Andy J. Miller; Anne Shea Gaza; Arthur G. Connolly , III; Benjamin J. Schladweiler; Bindu Ann George Palapura; Brian Sodikoff; Christopher B. Ferenc; Christopher M. Bruno; Christopher P. Galligan; David A. Bilson; David Ellis Moore; Dominick T. Gattuso; Don J. Mizerk; Dustin L. Taylor; Emily N. Winfield; Erin M. Forbes; Erin R. Conway; Eve H. Ormerod; Frank D. Rodriguez; Frederick R. Ball; Gary Ji; George C. Lombardi; George J. Barry , III; Huiya Wu; Imron T. Aly; James B. Monroe; James P. Barabas; James S. Green , Jr.; Jeanette M. Roorda; Jeffer Ali; Jing Xia; John C. Phillips , Jr.; John R. McNair; Jonathan B. Turpin; Joseph E. Cwik; Joseph M. Reisman; Jovial Wong; Kelly E. Farnan; Kenton M. Walker; Kevin E. Warner; Li Feng; Loni L. Morrow; Mark Rubinshtein; Matthew M. Holub; Michael J. Gaertner; Michelle A. Herrera; Naomi L. Birbach; Neal C. Belgam; Patrick C. Gallagher; Paul W. Browning; Philip D. Segrest; Philip Y. Braginsky; Pilar Gabrielle Kraman; Rachel P. Waldron; Rajendra A. Chiplunkar; Richard L. Renck; Samantha G. Wilson; Samuel Sherry; Sanya Sukduang; Sara E. Bussiere; Saukshmya Trichi; Scott B. Feder; Shailendra K. Maheshwari; Stamatios Stamoulis; Stephen B. Brauerman; Steven J. Balick; Steven J. Moore; Thomas H. Ehrich; Thomas P. Krzeminski; Timothy F. Peterson; Timothy H. Kratz; Todd S. Werner; Vincent L. Capuano; William A. Rakoczy; William R. Zimmerman; Yun Wei
Firms	Bayard, P.A.; Duane Morris, LLP; Greenberg Traurig, the Nemours Building; Heyman Enerio Gattuso & Hirzel LLP; Phillips, Goldman, McLaughlin & Hall, P.A.; Smith, Katzenstein, & Jenkins LLP; Stamoulis & Weinblatt LLC; Young, Conaway, Stargatt & Taylor LLP
Link to Docket	External link to docket

Small Molecule Drugs cited in Biogen International GmbH v. Amneal Pharmaceuticals LLC

The small molecule drug covered by the patents cited in this case is Start Trial .

Details for Biogen International GmbH v. Amneal Pharmaceuticals LLC (D. Del. 2017)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Date Filed	Document No.	Description	Snippet	Link To Document
2019-03-07	236	Opinion - Memorandum Opinion	alleging infringement of U.S. Patent Nos. 6,509,376 ("the ' 376 patent"), 7,320,999 ("the… 514 patent") (collectively, "patents-in-suit" or "asserted patents"). …;the ' 999 patent"), 7,619,001 ("the ' 001 patent"), 7,803 ,840 ("the '…#39; 840 patent"), 8,759,393 ("the ' 393 patent"), and 8,399,514 ("the ' 514…quot;It is a bedrock principle of patent law that the claims of a patent define the invention to which the	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys

Harvard Business School

McKesson

Baxter

Johnson and Johnson

AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.